SCHEMBL8104770

SCHEMBL8104770

Cc1ccc(N2CC(COc3ccc(C=O)cc3)OC2=O)cc1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 17/20 0.74
SIGMAR1 Q99720 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8120087 0.94 GRM2 (0.67) GRM2
SCHEMBL8115869 0.91 GRM2 (0.74) GRM2SIGMAR1
SCHEMBL8114180 0.88 GRM2 (0.74) GRM2
SCHEMBL8113455 0.88 GRM2 (0.79) GRM2
SCHEMBL8118809 0.87 GRM2 (0.59) GRM2
SCHEMBL8120132 0.84 GRM2 (0.74) GRM2SIGMAR1
SCHEMBL11009507 0.83 GRM2 (0.52) GRM2
SCHEMBL21581720 0.79 GRM2 (0.66) GRM2SIGMAR1
SCHEMBL8942129 0.78 GRM2 (0.56) GRM2
SCHEMBL7909523 0.77 GRM2 (0.49) GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0605729-B1 OXAZOLIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2000-07-26 EP disclosed
US-5480899-A ANTILIPEMIC AGENTS TAIHO PHARMACEUTICAL CO., LTD. (JP) 1996-01-02 US disclosed
EP-0605729-A1 OXAZOLIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 1994-07-13 EP disclosed